Cargando…
The Anti-Inflammatory Effect of Novel Antidiabetic Agents
The incidence of type 2 diabetes (T2DM) has been increasing worldwide and remains one of the leading causes of atherosclerotic disease. Several antidiabetic agents have been introduced in trying to regulate glucose control levels with different mechanisms of action. These agents, and sodium-glucose...
Autores principales: | Theofilis, Panagiotis, Sagris, Marios, Oikonomou, Evangelos, Antonopoulos, Alexios S., Siasos, Gerasimos, Tsioufis, Kostas, Tousoulis, Dimitris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696750/ https://www.ncbi.nlm.nih.gov/pubmed/36362984 http://dx.doi.org/10.3390/life12111829 |
Ejemplares similares
-
Inflammatory Mechanisms Contributing to Endothelial Dysfunction
por: Theofilis, Panagiotis, et al.
Publicado: (2021) -
Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
por: Sagris, Marios, et al.
Publicado: (2022) -
Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
por: Theofilis, Panagiotis, et al.
Publicado: (2021) -
Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
por: Theofilis, Panagiotis, et al.
Publicado: (2022) -
Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
por: Theofilis, Panagiotis, et al.
Publicado: (2022)